Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Share-based Compensation (2016 - 2022)

RedHill Biopharma has reported Share-based Compensation over the past 11 years, most recently at $1.1 million for Q4 2022.

  • Quarterly Share-based Compensation fell 39.36% to $1.1 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2022, down 44.43% year-over-year, with the annual reading at $457000.0 for FY2025, 31.28% down from the prior year.
  • Share-based Compensation was $1.1 million for Q4 2022 at RedHill Biopharma, down from $1.6 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $5.3 million in Q2 2021 and troughed at $468000.0 in Q3 2018.
  • The 5-year median for Share-based Compensation is $839000.0 (2018), against an average of $1.3 million.
  • Year-over-year, Share-based Compensation skyrocketed 746.55% in 2021 and then plummeted 88.28% in 2022.
  • A 5-year view of Share-based Compensation shows it stood at $671000.0 in 2018, then grew by 11.62% to $749000.0 in 2019, then skyrocketed by 44.46% to $1.1 million in 2020, then soared by 73.29% to $1.9 million in 2021, then crashed by 39.36% to $1.1 million in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Share-based Compensation are $1.1 million (Q4 2022), $1.6 million (Q3 2022), and $618000.0 (Q2 2022).